The Story Behind the ‘Miracle’ of GLP-1 Medications: Dr. John Buse, Chief of Endocrinology at University of North Carolina School of Medicine

“It’s kind of a miracle, frankly,” says Dr. John Buse, a distinguished professor at the University of North Carolina School of Medicine, referring to the effectiveness of GLP-1 receptor agonist medications such as Ozempic in treating type 2 diabetes, promoting significant weight loss, and reducing cardiovascular risk. As a physician scientist for the last three decades at UNC, Dr. Buse has played…